Monitor for any future conversion to a Schedule 13D (activist filing) or further stake changes. The increase to 8.6% by a hedge fund manager could precede engagement, but the passive filing suggests no immediate activist intent.
PALI drugs
PALI drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $1.13entry
- T+1 · 6d ago +3.54%α +2.22% · $1.17
- T+4 · todayOpen
- T+5 · in 4h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Soleus Capital Master Fund, L.P. filed an amended Schedule 13G disclosing a 8.6% passive stake in Palisade Bio, Inc., holding 14,996,154 shares as of September 30, 2026. This is an increase from the prior filing by Vanguard (5.16%) and from Soleus's own prior filing (not provided in detail), indicating continued accumulation by a hedge fund manager. The filing remains passive (Rule 13d-1(c)), with no activist intent signaled.
Key Financial Metrics
Key Facts
- Soleus Capital Master Fund, L.P. holds 14,996,154 shares of Palisade Bio common stock, representing 8.6% of shares outstanding as of September 30, 2026.
- The percentage is based on 174,270,558 shares outstanding as of August 6, 2026 (per the issuer's Form 10-Q).
- The filing is an amendment to Schedule 13G, indicating a passive investment under Rule 13d-1(c).
- Soleus Capital, LLC is the general partner; Soleus Capital Group, LLC is the managing member; Soleus Capital Management, L.P. is the investment manager; Guy Levy is the sole managing member of the relevant entities.
Financial Impact
14,996,154 shares, 8.6% stake, valued at approximately $17.2M based on market cap of $202M.
Risk Factors
- Potential future conversion to activist filing (13D) if Soleus Capital changes its intent.
- Further accumulation or sale could impact stock price given the 4.7% normal daily move.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001213900-26-117542 |
| Document: 0001213900-26-117542-index.html | 0001213900-26-117542 |
| Document: 0001213900-26-117542.txt | 0001213900-26-117542 |
Track record
14 reports on PALI
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $1.08 Now $1.03 −4.19% settles Dec 15
- Nov 10, 20266d ago 8-K Neutral 5/10 Entry $1.17 Now $1.03 −11.97% settles Dec 10
- Nov 9, 20267d ago SC 13G/A Neutral 3/10 Viewing Entry $1.13 Now $1.03 −8.85% settles Dec 9
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $1.16 Now $1.03 −11.21% settles Nov 30
- Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $1.69 to $1.43 Now $1.03 −39.05% ▼ −15.38% −14.82% vs SPY
- Sep 22, 20267w ago Press Release Bullish 6/10 Entry $1.69 to $1.43 Now $1.03 −39.05% ▼ −15.38% −14.82% vs SPY
- Aug 10, 202614w ago 8-K Neutral 5/10 Entry $2.14 to $2.05 Now $1.03 −51.87% ▼ −4.21% −3.15% vs SPY
- Jul 10, 202618w ago Insider Cluster Neutral 2/10 Entry $1.89 to $2.10 Now $1.03 −45.50% ▲ +11.11% +7.93% vs SPY
- Jul 8, 202618w ago Insider Cluster Neutral 3/10 Entry $1.97 to $2.09 Now $1.03 −47.72% ▲ +6.09% +3.85% vs SPY
- Jun 11, 202622w ago 8-K Neutral 4/10 Entry $1.71 to $1.96 Now $1.03 −39.77% ▲ +14.62% +12.84% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers